Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 2 4Phase 4 2Phase 1/2 1Phase 1 1

Status

Completed 3Terminated 1

Sponsor Class

INDUSTRY 2OTHER 1INDIV 1

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 2760Carcinoma, Non-Small-Cell Lung 2260Prostatic Neoplasms 1425Colorectal Neoplasms 1290Neoplasms 1258Multiple Myeloma 1084Lung Neoplasms 1048Neoplasm Metastasis 994Leukemia, Myeloid, Acute 984Lymphoma 900Melanoma 862Pancreatic Neoplasms 818Ovarian Neoplasms 805Carcinoma, Hepatocellular 782Stomach Neoplasms 753Recurrence 750Leukemia 733Lymphoma, Non-Hodgkin 684Leukemia, Lymphocytic, Chronic, B-Cell 665Lymphoma, Large B-Cell, Diffuse 616Squamous Cell Carcinoma of Head and Neck 615Precursor Cell Lymphoblastic Leukemia-Lymphoma 605Head and Neck Neoplasms 596Brain Neoplasms 592Carcinoma, Renal Cell 586Glioblastoma 572Rectal Neoplasms 563Myelodysplastic Syndromes 522Sarcoma 521Lymphoma, Follicular 516

Interventions

ruxolitinib 1macimorelin 1RC-1291 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Cancer Cachexia × Clear all
NCT01614990 2024-03-20

Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia

Garcia, Jose M., MD, PhD

Phase 2 Completed
15 enrolled 35 charts

Cancer Cachexia

NCT02072057 2019-02-28

Study of Ruxolitinib in the Treatment of Cachexia in Patients With Tumor-Associated Chronic Wasting Diseases.

Kantonsspital Aarau

Phase 2 Terminated
8 enrolled

Cancer Cachexia

NCT00267358 2013-09-02

Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.

Helsinn Therapeutics (U.S.), Inc

Phase 2 Completed

Cancer Cachexia

NCT00378131 2013-09-02

Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia

Helsinn Therapeutics (U.S.), Inc

Phase 2 Completed
51 enrolled

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡